List View

By /

Clear

Displaying 2,626 - 2,650 of 2,995

EGFR Exon 20 Insertions: Novel Agents

EGFR Exon 20 Insertions: Novel Agents

ALK: First Line and Mechanism Of Resistance

ALK: First Line and Mechanism Of Resistance

K-RAS Therapies in NSCLC

K-RAS Therapies in NSCLC

Other Driver Mutations: ROS-1, BRAF, MET and RET

Other Driver Mutations: ROS-1, BRAF, MET and RET

Non Driver NSCLC: The Immunotherapy Strategy

Non Driver NSCLC: The Immunotherapy Strategy

Small Cell Lung Cancer: Targeting This Difficult Target

Small Cell Lung Cancer: Targeting This Difficult Target

Novel Advances in T-Cell NHL Therapies

Novel Advances in T-Cell NHL Therapies

Navigating Mantle Cell Lymphoma in the Era of Targeted Therapy

Navigating Mantle Cell Lymphoma in the Era of Targeted Therapy

CLL: Therapeutic Advances in 2024

CLL: Therapeutic Advances in 2024

Targeted Therapy in Hema Malignancies (CD20, CD30, CD33, BCR/ABL, FLT3, IDH1/2)

Targeted Therapy in Hema Malignancies (CD20, CD30, CD33, BCR/ABL, FLT3, IDH1/2)

De Novo Acute Myeloid Leukemia

De Novo Acute Myeloid Leukemia

CAR-T Cell Therapy in Lymphomas: 7-Years Later

CAR-T Cell Therapy in Lymphomas: 7-Years Later

Acquired Inhibitors in Cancer: State-of-the Art Management

Acquired Inhibitors in Cancer: State-of-the Art Management

Sequencing Therapy in Relapsed/Refractory Myeloma Patients

Sequencing Therapy in Relapsed/Refractory Myeloma Patients

Role of Pharmacist in Vaccination: Challenges and Opportunities

Role of Pharmacist in Vaccination: Challenges and Opportunities

Neurology Drug Update

Neurology Drug Update

Diabetes Management in the Face of Healthcare Disparities

Diabetes Management in the Face of Healthcare Disparities

Cancer Care Disparities in Puerto Rico (Part 1)

Cancer Care Disparities in Puerto Rico (Part 1)

Malignant Hematology and Use of Bi-specifics in Puerto Rico

Malignant Hematology and Use of Bi-specifics in Puerto Rico

Leveraging NCODA Resources to Manage Patients on Oral Oncolytics

Leveraging NCODA Resources to Manage Patients on Oral Oncolytics

Obesity Management with Incretin Therapies: Considerations for Patients with and without Type 2 Diabetes

Obesity Management with Incretin Therapies: Considerations for Patients with and without Type 2 Diabetes

Post Neoadjuvant Chemotherapy and the Axilla

Post Neoadjuvant Chemotherapy and the Axilla

Denovo Metastatic Breast and the Role of Surgery

Denovo Metastatic Breast and the Role of Surgery

Breast Cancer – Transgender Construction and Deconstruction

Breast Cancer – Transgender Construction and Deconstruction

LCIS and ILC – Old Story with New Concerns

LCIS and ILC – Old Story with New Concerns